By Tracy Manning, DDSTUDIO Chief Strategy Officer From “zero to commercial” in two years—a savings of at least $5 million and three-to-four years research and development—that is the return on investment BioFluidica CEO Rolf Muller, Ph.D., attributes to human-centered design. Muller, a successful veteran of the biotechnology industry, engaged with DDSTUDIO and its human-centered design …

Read More